Holen Sie sich die Stockscreener-App
1.11
11.90%
-0.15
Handel nachbörslich:
1.05
-0.06
-5.41%
Schlusskurs vom Vortag:
$1.26
Offen:
$1.22
24-Stunden-Volumen:
839.98K
Relative Volume:
1.15
Marktkapitalisierung:
$7.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.63%
1M Leistung:
-4.31%
6M Leistung:
-32.32%
1J Leistung:
-90.55%
1-Tages-Spanne:
$1.08
$1.22
1-Wochen-Bereich:
$1.08
$1.3502
52-Wochen-Spanne:
$0.9612
$21.49
Autonomix Medical Inc Stock (AMIX) Company Profile
Firmenname
Autonomix Medical Inc
Sektor
Branche
Telefon
832-277-7816
Adresse
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Vergleichen Sie AMIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
1.11 | 7.80M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix Medical Inc. stock trend forecastJuly 2025 Setups & Safe Swing Trade Setup Alerts - newser.com
What earnings revisions data tells us about Autonomix Medical Inc.July 2025 Institutional & Weekly Top Performers Watchlists - newser.com
Published on: 2025-10-10 05:41:12 - newser.com
Is this a good reentry point in Autonomix Medical Inc.2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com
Autonomix receives new US patent for cardiac nerve treatment tech By Investing.com - Investing.com Nigeria
Autonomix Medical stock rises after securing new cardiac treatment patent By Investing.com - Investing.com Australia
Autonomix Medical stock rises after securing new cardiac treatment patent - Investing.com
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - The Manila Times
Autonomix Medical, Inc. Strengthens IP Portfolio with New Patent for Precision Nerve-Targeted Cardiac Treatments - Quiver Quantitative
Autonomix Medical, Inc. Granted U.S. Patent on Platform - GlobeNewswire
U.S. Patent 12,369,852: Autonomix Expands 120+ Patent Portfolio to Advance Cardiac Nerve Therapies - Stock Titan
Risk vs reward if holding onto Autonomix Medical Inc.Trade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
Autonomix Medical Inc. stock trend outlook and recovery pathWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
Will Autonomix Medical Inc. stock deliver shareholder valueEntry Point & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-10-09 04:46:29 - newser.com
Is Autonomix Medical Inc. stock recession proofWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
How to build a dashboard for Autonomix Medical Inc. stockWeekly Volume Report & Smart Money Movement Alerts - newser.com
Is Autonomix Medical Inc. trending in predictive chart modelsQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Market reaction to Autonomix Medical Inc.’s recent news2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
How sentiment analysis helps forecast Autonomix Medical Inc.2025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment - The Manila Times
Medical Device Pioneer Autonomix Medical Details Nerve Treatment Progress, Sets 2026 U.S. Trial Launch - Stock Titan
Autonomix Medical registers 2.5M shares for resale under $15M equity deal with Lincoln Park - MSN
How to forecast Autonomix Medical Inc. trends using time seriesMarket Performance Report & Daily Stock Momentum Reports - newser.com
Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System - GlobeNewswire
Autonomix begins FDA-required GLP study for nerve treatment device By Investing.com - Investing.com South Africa
Autonomix begins FDA-required GLP study for nerve treatment device - Investing.com
Autonomix Medical Initiates Key GLP Preclinical Study to Advance Regulatory Pathway for Sensing and RF Ablation System - Quiver Quantitative
Autonomix Medical, Inc. Initiates Good Laboratory Practice Study for Sensing and RF Ablation System - MarketScreener
Finanzdaten der Autonomix Medical Inc-Aktie (AMIX)
Es liegen keine Finanzdaten für Autonomix Medical Inc (AMIX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):